Product Information

METHYLPHENIDATE ER(LA) 10 MG CP is a generic product labeled by Sandoz Inc., priced at $2.3035 per EA under NDC 00781238301. Its NADAC has been published 69 times since Apr 30, 2025.

FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the methylphenidate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

METHYLPHENIDATE ER(LA) 10 MG CP

methylphenidate
$2.3035per EA
Low Outlier
DEA Schedule CII

Strength

10 mg/1

Manufacturer

Sandoz Inc.

NDC

00781238301

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021284

FDA Approved

6/5/2002

TE Code

AB1

On Market Since

11/24/2015

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER(LA) 10 MG CP has been published 69 times since Apr 30, 2025, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.

Current price$2.3035 per EA
All-time high$4.2377 (Aug 13, 2025)
All-time low$2.3035 (Aug 19, 2026)
52-week high$3.9957
52-week low$2.3035
Median price$3.6491
Average price$3.3661
Largest weekly change-14.7% (Mar 18, 2026)
Weeks tracked69
Tracking sinceApr 30, 2025

Price History

1W

-1.6%

1M

-1.6%

3M

-3.4%

6M

-29.8%

1Y

-42.4%

3Y

N/A

5Y

N/A

All

-35.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER(LA) 10 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 10 MG CP, manufactured by Sandoz Inc., is $2.3035 per EA (NDC 00781238301), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE ER(LA) 10 MG CP changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 10 MG CP has declined 35.5%. It has been tracked across 69 weekly CMS publications since Apr 30, 2025.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 10 MG CP?

Since Apr 30, 2025, the NADAC for METHYLPHENIDATE ER(LA) 10 MG CP has ranged from a low of $2.3035 (Aug 19, 2026) to a high of $4.2377 (Aug 13, 2025), with a median of $3.6491 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 10 MG CP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER(LA) 10 MG CP in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE ER(LA) 10 MG CP?

METHYLPHENIDATE ER(LA) 10 MG CP (NDC 00781238301) is labeled by Sandoz Inc., and CMS classifies it as a generic product.